Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Predictive Biomarkers for Successful Salvage Surgeries on PSMA-PET-positive Limited Metastatic Prostate Cancer Relapses

NCT04324983 is registered in ClinicalTrials.gov with Martini-Klinik am UKE GmbH as lead sponsor.

NCT NCT04324983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04324983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Predictive Biomarkers for Successful Salvage Surgeries on PSMA-PET-positive Limited Metastatic Prostate Cancer Relapses
Lead sponsor
Martini-Klinik am UKE GmbH
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2020
Completion date
April 5, 2023
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer recurrent